reported that lymphopenia, CD3+, CD3+CD4+, CD3+CD8+ T lymphocytes, B lymphocytes, NK cells, and CD4+/CD8+ ratios were lower in patients with NSCLC who received radiotherapy (34). This evidence concerns the gene CD4 and non-small cell lung carcinoma.